Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) compared with standard chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane Database Syst Rev
Hauptverfasser: Moraes, Fabio Y, Perry, Luke A, Penny‐Dimri, Jahan C, Ramson, Dhruvesh, de Castria, Tiago B, Bowman, Rayleen V, Santos, Fábio N, Fong, Kwun M, Riera, Rachel
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Ltd 2017
Schlagworte:
Medicine General & Introductory Medical Sciences
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478330/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012644
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge